Literature DB >> 31361589

Who receives naloxone from emergency medical services? Characteristics of calls and recent trends.

Caroline Geiger1,2, Rosanna Smart3, Bradley D Stein2,4.   

Abstract

Background: With the rapid rise in opioid overdose-related deaths, state policy makers have expanded policies to increase the use of naloxone by emergency medical services (EMS). However, little is known about changes in EMS naloxone administration in the context of continued worsening of the opioid crisis and efforts to increase use of naloxone. This study examines trends in patient demographics and EMS response characteristics over time and by county urbanicity.
Methods: We used data from the 2013-2016 National EMS Information System to examine trends in patient demographics and EMS response characteristics for 911-initiated incidents that resulted in EMS naloxone administration. We also assessed temporal, regional, and urban-rural variation in per capita rates of EMS naloxone administrations compared with per capita rates of opioid-related overdose deaths.
Results: From 2013 to 2016, naloxone administrations increasingly involved young adults and occurred in public settings. Particularly in urban counties, there were modest but significant increases in the percentage of individuals who refused subsequent treatment, were treated and released, and received multiple administrations of naloxone before and after arrival of EMS personnel. Over the 4-year period, EMS naloxone administrations per capita increased at a faster rate than opioid-related overdose deaths across urban, suburban, and rural counties. Although national rates of naloxone administration were consistently higher in suburban counties, these trends varied across U.S. Census Regions, with the highest rates of suburban administration occurring in the South. Conclusions: Naloxone administration rates increased more quickly than opioid deaths across all levels of county urbanicity, but increases in the percentage of individuals requiring multiple doses and refusing subsequent care require further attention.

Entities:  

Keywords:  Naloxone; drug overdose; emergency medical services; opioids

Year:  2019        PMID: 31361589      PMCID: PMC6989345          DOI: 10.1080/08897077.2019.1640832

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  32 in total

1.  The ratio of non-fatal to fatal heroin overdose.

Authors:  Shane Darke; Richard P Mattick; Louisa Degenhardt
Journal:  Addiction       Date:  2003-08       Impact factor: 6.526

2.  National Systematic Legal Review of State Policies on Emergency Medical Services Licensure Levels' Authority to Administer Opioid Antagonists.

Authors:  Jeremiah M Kinsman; Kathy Robinson
Journal:  Prehosp Emerg Care       Date:  2018-02-27       Impact factor: 3.077

3.  The U.S. opioid epidemic: One disease, diverging tales.

Authors:  Ryan McBain; Adam J Rose; Marc R LaRochelle
Journal:  Prev Med       Date:  2018-04-21       Impact factor: 4.018

4.  Effect of Age on Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011 to 2015.

Authors:  Adam J Rose; Ryan McBain; Megan S Schuler; Marc R LaRochelle; David A Ganz; Vikram Kilambi; Bradley D Stein; Dana Bernson; Kenneth Kwan Ho Chui; Thomas Land; Alexander Y Walley; Thomas J Stopka
Journal:  J Am Geriatr Soc       Date:  2018-11-24       Impact factor: 5.562

5.  Description of the 2012 NEMSIS public-release research dataset.

Authors:  N Clay Mann; Lauren Kane; Mengtao Dai; Karen Jacobson
Journal:  Prehosp Emerg Care       Date:  2014-10-07       Impact factor: 3.077

6.  Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing.

Authors:  Mark Faul; Peter Lurie; Jeremiah M Kinsman; Michael W Dailey; Charmaine Crabaugh; Scott M Sasser
Journal:  Prehosp Emerg Care       Date:  2017-05-08       Impact factor: 3.077

7.  Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.

Authors:  Nadia Fairbairn; Phillip O Coffin; Alexander Y Walley
Journal:  Int J Drug Policy       Date:  2017-07-04

8.  US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.

Authors:  George Jay Unick; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-05

9.  EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana.

Authors:  Bradley R Ray; Evan M Lowder; Aaron J Kivisto; Peter Phalen; Harold Gil
Journal:  Addiction       Date:  2018-09-26       Impact factor: 6.526

10.  Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.

Authors:  Jake R Morgan; Bruce R Schackman; Zoe M Weinstein; Alexander Y Walley; Benjamin P Linas
Journal:  Drug Alcohol Depend       Date:  2019-05-03       Impact factor: 4.852

View more
  6 in total

1.  Patient perceptions of higher-dose naloxone nasal spray for opioid overdose.

Authors:  Justin C Strickland; Katherine R Marks; Kirsten E Smith; Jennifer D Ellis; J Gregory Hobelmann; Andrew S Huhn
Journal:  Int J Drug Policy       Date:  2022-05-26

2.  Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin.

Authors:  Phillip O Coffin; Sigal Maya; James G Kahn
Journal:  Drug Alcohol Depend       Date:  2022-04-29       Impact factor: 4.852

3.  Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.

Authors:  Kelly Quinn; Sagar Kumar; Calli T Hunter; Julie O'Donnell; Nicole L Davis
Journal:  Drug Alcohol Depend       Date:  2022-04-16       Impact factor: 4.852

4.  Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.

Authors:  Randa Abdelal; A Raja Banerjee; Suzanne Carlberg-Racich; Neyla Darwaza; Diane Ito; Jessica Shoaff; Josh Epstein
Journal:  Harm Reduct J       Date:  2022-05-20

Review 5.  Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.

Authors:  Rosanna Smart; Bryce Pardo; Corey S Davis
Journal:  Addiction       Date:  2020-07-08       Impact factor: 6.526

6.  Predictors of having naloxone in urban and rural Oregon findings from NHBS and the OR-HOPE study.

Authors:  Lauren Lipira; Gillian Leichtling; Ryan R Cook; Judith M Leahy; E Roberto Orellana; P Todd Korthuis; Timothy W Menza
Journal:  Drug Alcohol Depend       Date:  2021-07-21       Impact factor: 4.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.